Story file
How to verify a peptide COA is real, and what it leaves open
Four checks the category uses to verify a peptide COA, set against the two conditions 21 CFR 211.84(d)(2) puts on relying on a supplier's analysis.
To verify a peptide COA is real, check four things: the lot number on the report matches the vial label, the issuing laboratory is named, the HPLC chromatogram and mass spectrum are attached, and the laboratory itself confirms the report ID. Those checks show the document is authentic. None of them shows the vial in hand is the sample tested.
That last sentence is the part this guide is built around. This desk read the text of 21 CFR 211.84 on the Cornell Legal Information Institute site on 23 September 2026, and it gives a useful benchmark for how far a supplier’s paperwork can be relied on. This is an evergreen how-to, not a news item.
What does US drug manufacturing require before relying on a supplier’s report?
Section 211.84(d)(2) is part of FDA’s current good manufacturing practice rules for finished drugs. It says a report of analysis may be accepted from the supplier of a component on two conditions. The manufacturer must run at least one specific identity test itself. And it must establish the reliability of the supplier’s analyses through validation of the supplier’s results at appropriate intervals. The section’s history line shows it was last amended at 73 FR 51932, 8 September 2008.
The rule binds drug manufacturers. It does not apply to research-use peptide buyers or sellers, and nothing here suggests any vendor, laboratory or COA is FDA-regulated. It is used below as a documentary yardstick only.
How to verify a peptide COA is real, check by check
Condition A is the buyer’s own identity test. Condition B is validation of the supplier’s results over time.
| Check | What it establishes | 211.84(d)(2) condition | What stays open |
|---|---|---|---|
| Lot number on report matches vial label | Report and vial carry the same identifier | Neither | Whether the contents are what the lot was |
| Issuing laboratory named | Who claims to have run the test | Neither on its own | Whether the method was fit for this peptide |
| Chromatogram and mass spectrum attached | The raw basis for the purity and identity figures | Neither: still the supplier’s analysis | Whether the traces belong to this lot |
| Laboratory confirms the report ID | The document is the laboratory’s own copy | Part of B, once | Whether this vial is the sample tested |
No row satisfies Condition A. Only a test run on the material in hand does that.
The top-ranking guides this desk read for this query describe versions of these checks. One walks through a report lookup on Janoshik Analytical’s verification site. In the portions read, none of the three cites 21 CFR 211.84 or any other benchmark for relying on a supplier’s analysis.
What the traces themselves show is covered in what MS confirms that HPLC purity cannot. How lot numbers travel from report to label is in lot traceability and vial labelling, assessed.
What does enforcement of the rule look like?
FDA’s Warning Letter 320-25-98, dated 6 August 2025 and read by this desk on 23 September 2026, went to ABBE Laboratories of Farmingdale, New York. It cites 211.84(d)(1) and (d)(2): the firm relied on suppliers’ COAs without establishing the reliability of their analyses. FDA asked for initial validation and periodic revalidation of supplier results, plus at least one specific identity test for each incoming lot. The products were over-the-counter topical liquids and ointments, not peptides, and a warning letter records FDA’s findings, not a court’s.
The point for a research buyer is narrow. Even where the rule applies, a supplier’s certificate is never accepted on its own. A vendor-published COA read as evidence carries the same limit.
Questions readers ask
What should a peptide certificate of analysis include?
At minimum: the compound name, a lot number that matches the vial label, the issuing laboratory’s name, the test date, an HPLC purity figure with its chromatogram, and a mass spectrometry result comparing observed with theoretical mass. A report that names no laboratory, or quotes figures without the traces behind them, gives a reader nothing to check.
Can a certificate of analysis be faked?
Yes. A COA is a document, and documents can be edited, reused across lots or invented outright. That is why the checks above start with the document itself: does the lot match, is a laboratory named, and will that laboratory confirm the report. A report that fails any of these has not earned the next question.
What is a third-party COA?
A certificate issued by a testing laboratory independent of the vendor, rather than by the vendor or its manufacturer. Independence changes who ran the analysis. It does not change what the analysis covers: a third-party report still describes the sample the laboratory received, which is why the lot match and the confirmation step matter.
None of this is about what a peptide does. The materials on these certificates are supplied for laboratory research use only, and the only question this desk asks of a COA is how much of it can be checked.